radiotherapy in gynecological malignancies

  1. Yang B, Zhu L, Cheng H, Li Q, Zhang Y, Zhao Y. Dosimetric comparison of intensity modulated radiotherapy and three-dimensional conformal radiotherapy in patients with gynecologic malignancies: a systematic review and meta-analysis. Radiat Oncol. 2012 Nov 23;7:197. doi: 10.1186/1748-717X-7-197. PMID: 23176540; PMCID: PMC3539899.
  2. Delaney G, Jacob S, Featherstone C, Barton M. The role of radiotherapy in cancer treatment: estimating optimal utilization from a review of evidence-based clinical guidelines. Cancer. 2005 Sep 15;104(6):1129-37. doi: 10.1002/cncr.21324. Erratum in: Cancer. 2006 Aug 1;107(3):660. PMID: 16080176.
  3. Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part I–malignancies of the cervix, ovary, vagina and vulva. Cancer. 2004 Aug 15;101(4):671-81. doi: 10.1002/cncr.20444. PMID: 15305396.
  4. Delaney G, Jacob S, Barton M. Estimation of an optimal radiotherapy utilization rate for gynecologic carcinoma: part II–carcinoma of the endometrium. Cancer. 2004 Aug 15;101(4):682-92. doi: 10.1002/cncr.20445. PMID: 15305397.
  5. Herrmann H, Seppenwoolde Y, Georg D, Widder J. Image guidance: past and future of radiotherapy. Radiologe. 2019 Dec;59(Suppl 1):21-27. doi: 10.1007/s00117-019-0573-y. PMID: 31346650; PMCID: PMC6914710.
  6. Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer. 2018 Aug;119(4):389-407. doi: 10.1038/s41416-018-0201-z. Epub 2018 Jul 31. PMID: 30061587; PMCID: PMC6117262.
  7. Mundt AJ, Lujan AE, Rotmensch J, Waggoner SE, Yamada SD, Fleming G, Roeske JC. Intensity-modulated whole pelvic radiotherapy in women with gynecologic malignancies. Int J Radiat Oncol Biol Phys. 2002 Apr 1;52(5):1330-7. doi: 10.1016/s0360-3016(01)02785-7. PMID: 11955746.
  8. Heron DE, Gerszten K, Selvaraj RN, King GC, Sonnik D, Gallion H, Comerci J, Edwards RP, Wu A, Andrade RS, Kalnicki S. Conventional 3D conformal versus intensity-modulated radiotherapy for the adjuvant treatment of gynecologic malignancies: a comparative dosimetric study of dose-volume histograms. Gynecol Oncol. 2003 Oct;91(1):39-45. doi: 10.1016/s0090-8258(03)00461-x. PMID: 14529660.
  9. Lujan AE, Mundt AJ, Yamada SD, Rotmensch J, Roeske JC. Intensity-modulated radiotherapy as a means of reducing dose to bone marrow in gynecologic patients receiving whole pelvic radiotherapy. Int J Radiat Oncol Biol Phys. 2003 Oct 1;57(2):516-21. doi: 10.1016/s0360-3016(03)00521-2. PMID: 12957265.
  10. Mundt AJ, Mell LK, Roeske JC. Preliminary analysis of chronic gastrointestinal toxicity in gynecology patients treated with intensity-modulated whole pelvic radiation therapy. Int J Radiat Oncol Biol Phys. 2003 Aug 1;56(5):1354-60. doi: 10.1016/s0360-3016(03)00325-0. PMID: 12873680.
  11. Lin Y, Chen K, Lu Z, Zhao L, Tao Y, Ouyang Y, Cao X. Intensity-modulated radiation therapy for definitive treatment of cervical cancer: a meta-analysis. Radiat Oncol. 2018 Sep 14;13(1):177. doi: 10.1186/s13014-018-1126-7. PMID: 30217165; PMCID: PMC6137729.
  12. Klopp AH, Yeung AR, Deshmukh S, Gil KM, Wenzel L, Westin SN, Gifford K, Gaffney DK, Small W Jr, Thompson S, Doncals DE, Cantuaria GHC, Yaremko BP, Chang A, Kundapur V, Mohan DS, Haas ML, Kim YB, Ferguson CL, Pugh SL, Kachnic LA, Bruner DW. Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology-RTOG 1203. J Clin Oncol. 2018 Aug 20;36(24):2538-2544. doi: 10.1200/JCO.2017.77.4273. Epub 2018 Jul 10. Erratum in: J Clin Oncol. 2019 Mar 20;37(9):761. Erratum in: J Clin Oncol. 2020 Apr 1;38(10):1118. PMID: 29989857; PMCID: PMC6097832.
  13. Folkert MR, Shih KK, Abu-Rustum NR, Jewell E, Kollmeier MA, Makker V, Barakat RR, Alektiar KM. Postoperative pelvic intensity-modulated radiotherapy and concurrent chemotherapy in intermediate- and high-risk cervical cancer. Gynecol Oncol. 2013 Feb;128(2):288-93. doi: 10.1016/j.ygyno.2012.11.012. Epub 2012 Nov 15. PMID: 23159818.
  14. Gandhi AK, Sharma DN, Rath GK, Julka PK, Subramani V, Sharma S, Manigandan D, Laviraj MA, Kumar S, Thulkar S. Early clinical outcomes and toxicity of intensity modulated versus conventional pelvic radiation therapy for locally advanced cervix carcinoma: a prospective randomized study. Int J Radiat Oncol Biol Phys. 2013 Nov 1;87(3):542-8. doi: 10.1016/j.ijrobp.2013.06.2059. PMID: 24074927.
  15. Cozzi L, Dinshaw KA, Shrivastava SK, Mahantshetty U, Engineer R, Deshpande DD, Jamema SV, Vanetti E, Clivio A, Nicolini G, Fogliata A. A treatment planning study comparing volumetric arc modulation with RapidArc and fixed field IMRT for cervix uteri radiotherapy. Radiother Oncol. 2008 Nov;89(2):180-91. doi: 10.1016/j.radonc.2008.06.013. Epub 2008 Aug 8. PMID: 18692929.
  16. Bai W, Kou C, Yu W, Li Y, Hua W, Yu L, Wang J. Dosimetric comparison of volumetric-modulated arc therapy and intensity-modulated radiation therapy in patients with cervical cancer: a meta-analysis. Onco Targets Ther. 2018 Oct 18;11:7179-7186. doi: 10.2147/OTT.S178336. PMID: 30425510; PMCID: PMC6203086
  17. Teoh M, Clark CH, Wood K, Whitaker S, Nisbet A. Volumetric modulated arc therapy: a review of current literature and clinical use in practice. Br J Radiol. 2011 Nov;84(1007):967-96. doi: 10.1259/bjr/22373346. PMID: 22011829; PMCID: PMC3473700.
  18. Shelley CE, Barraclough LH, Nelder CL, Otter SJ, Stewart AJ. Adaptive Radiotherapy in the Management of Cervical Cancer: Review of Strategies and Clinical Implementation. Clin Oncol (R Coll Radiol). 2021 Sep;33(9):579-590. doi: 10.1016/j.clon.2021.06.007. Epub 2021 Jul 9. PMID: 34247890.

Find More

Categories

Follow Us

Feel free to follow us on social media for the latest news and more inspiration.

Related Content